Automatic and renewable micro-solid-phase extraction based on bead injection lab-on-valve system for determination of tranexamic acid in urine by UHPLC coupled with tandem mass spectrometry

被引:0
作者
Sara R. Fernandes
Luisa Barreiros
Paula Sá
Manuel Miró
Marcela A. Segundo
机构
[1] Universidade do Porto,LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia
[2] Instituto Politécnico do Porto,Escola Superior de Saúde
[3] Centro Hospitalar Universitário do Porto,FI
[4] University of the Balearic Islands,TRACE group, Department of Chemistry
来源
Analytical and Bioanalytical Chemistry | 2022年 / 414卷
关键词
Bead injection; Lab-on-valve; Automation; Mass spectrometry; Tranexamic acid; Urine;
D O I
暂无
中图分类号
学科分类号
摘要
An automatic micro-solid-phase extraction (μSPE) method using on-line renewable sorbent beads followed by liquid chromatography–tandem mass spectrometry (LC–MS/MS) was established for the determination of tranexamic acid (TXA) in urine. The μSPE method was based on the bead injection (BI) concept combined with the mesofluidic lab-on-valve (LOV) platform. All steps of the μSPE–BI–LOV were implemented by computer programming, rendering enhanced precision on time and flow events. Several parameters, including the type of sorbent, volume and composition of the conditioning solution, washing solution, and eluent composition, were evaluated to improve the extraction efficiency. The best results were obtained with a hydrophilic–lipophilic balanced mixed-mode sorbent, decorated with sulfonic acid groups (Oasis MCX), and 99% acetonitrile–water (50:50, v/v)–1% ammonium hydroxide as eluent. Chromatographic separation was performed using a BEH amide column coupled to MS/MS detection in positive ionization mode. Good linearity was achieved (R2 > 0.998) for TXA concentrations in urine ranging from 300 to 3000 ng mL−1, with LOD and LOQ of 30 and 65 ng mL−1, respectively. Dilution integrity was observed for dilution factors up to 20,000 times, providing the extension of the upper limit of quantification to 12 mg mL−1. The method was validated according to international guidelines and successfully applied to urine samples collected during scoliosis surgery of pediatric patients treated with TXA.
引用
收藏
页码:649 / 659
页数:10
相关论文
共 148 条
[1]  
Tengborn L(2015)Tranexamic acid - an old drug still going strong and making a revival Thromb Res 135 231-242
[2]  
Blomback M(2020)The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients Eur J Haematol 104 79-87
[3]  
Berntorp E(2016)Tranexamic acid-associated seizures: causes and treatment Ann Neurol 79 18-26
[4]  
Cai J(2011)Tranexamic acid therapy for heavy menstrual bleeding Expert Opin Pharmacother 12 2089-2095
[5]  
Ribkoff J(2015)The current place of tranexamic acid in the management of bleeding Anaesthesia. 70 5-342
[6]  
Olson S(2017)Analytical methods for quantification of tranexamic acid in biological fluids: a review Microchem J 134 333-1332
[7]  
Raghunathan V(2018)Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen Anesth Analg 127 1323-317
[8]  
Al-Samkari H(2007)Optimization and validation of an HPLC-UV method for determination of tranexamic acid in a dosage form and in human urine Chromatographia. 66 311-380
[9]  
DeLoughery TG(1974)Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers Eur J Clin Pharmacol 7 375-146
[10]  
Shatzel JJ(2021)Therapeutic drug monitoring of tranexamic acid in plasma and urine of renally impaired patients using solid phase microextraction Talanta. 225 121945-302